HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Horikoshi Selected Research

M Horikoshi Research Topics

Disease

4Type 2 Diabetes Mellitus (MODY)
08/2009 - 07/2005
2Lung Neoplasms (Lung Cancer)
11/2000 - 01/2000
1Muscular Diseases (Myopathy)
11/2017
1Pathologic Constriction (Stenosis)
11/2017
1Glucose Intolerance
12/2012
1Arthritis (Polyarthritis)
05/2011
1Experimental Arthritis
05/2011
1Multiple Hereditary Exostoses (Hereditary Multiple Exostoses)
12/2007
1Obesity
12/2007
1Melanoma (Melanoma, Malignant)
03/2001
1Bronchogenic Carcinoma
11/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2000
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2000
1Stomach Neoplasms (Stomach Cancer)
01/2000
1Essential Thrombocythemia
01/2000

Drug/Important Bio-Agent (IBA)

1Signal Recognition ParticleIBA
11/2017
1Glucose (Dextrose)FDA LinkGeneric
12/2012
1LigandsIBA
05/2011
1GlycolipidsIBA
05/2011
1dicarboxydine (DCD)IBA
08/2009
1zinc-binding protein (zinc binding protein)IBA
12/2007
1Insulin-Like PeptidesIBA
12/2007
1Carrier Proteins (Binding Protein)IBA
12/2007
1Proteins (Proteins, Gene)FDA Link
12/2007
1Messenger RNA (mRNA)IBA
12/2007
1Cyclin-Dependent Kinase Inhibitor p15IBA
12/2007
1Transcription Factors (Transcription Factor)IBA
04/2007
1Adiponectin ReceptorsIBA
07/2005
1GadoliniumIBA
03/2001
1AntibodiesIBA
03/2001
1S100 Proteins (S 100 Protein)IBA
03/2001
1TechnegasIBA
11/2000
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2000
1TegafurIBA
01/2000
1Radioisotopes (Radionuclides)IBA
01/2000
1UracilIBA
01/2000

Therapy/Procedure

2Aftercare (After-Treatment)
11/2000 - 01/2000
1Drug Therapy (Chemotherapy)
01/2000
1Radiotherapy
01/2000
1Therapeutics
01/2000